Biopsy
B
Description
"Biopsy" test helps doctors examine tissue at a cellular level to diagnose infections, inflammation, or cancer. Depending on the concern, the sample may come from skin, bone marrow, or internal organs. The procedure can involve a needle, endoscope, or small incision. Once collected, the tissue is analyzed under a microscope to identify abnormal cells or disease. Biopsy results provide critical answers that guide treatment decisions, including surgery, medication, or further testing based on what’s found.
Category
Tissue Function
Procedure
Invasive
Sample Type
Tissue
Units
Not Applicable
Procedure Category
Incise, Extract
Test Group
Tissue Assessment Group
Test Group Description
Tissue Assessment Group: This group encompasses tests and procedures focused on assessing tissue samples for diagnostic purposes. These assessments provide valuable insights into cellular structure, morphology, and composition, aiding in the diagnosis and management of various medical conditions.
Optimal Range
For All Individuals:
Result: Negative: No abnormalities detected.
Normal Range
For All Individuals:
Result: Negative: No abnormalities detected.
Results That Differ From The Norm (Direct and Indirect Causes)
Abnormal results may indicate:
Atypical (cellular changes that deviate from the norm)
Carcinoma (cancer that originates in epithelial cells)
Dysplasia (abnormal development or growth of cells)
Hyperplasia (increase in the number of cells in an organ or tissue)
Leukemia (cancer of the blood or bone marrow)
Lymphoma (cancer of the lymphatic system)
Neoplasia (abnormal growth of cells that can be benign or malignant)
Sarcoma (cancer that originates in connective tissues such as bone, muscle, or fat)
Key Reasons For Testing
Diagnostic Purposes: Identifies conditions like cancer, infections, or autoimmune diseases by analyzing a small tissue sample.
Tumor Identification and Grading: Confirms tumor presence, type, and aggressiveness to guide treatment planning.
Assessment of Disease Severity: Evaluates tissue damage or changes to determine the condition's progression.
Treatment Selection: Provides detailed information to tailor the most effective treatment strategies.
Monitoring Treatment Response: Tracks effectiveness of treatments or recurrence of the condition through repeat biopsies.
Health Status Conditions It May Be Used To Assess
Currently, this test is not directly associated with any conditions listed on the Health Status page. However, it may be included as part of a broader set of tests linked to specific health conditions.
Some Prominent Medical Labs That May Offer This Test
Please note that this particular test has not been associated with any of the listed prominent medical labs. We recommend enquiring with your private physician or nearest hospital to determine where this specific test can be performed.
References
Important Note
Any medical procedure yielding results outside the norm may be directly or indirectly linked to the conditions outlined on this page. Various factors, including genetics, medication and supplement usage, recent illnesses, pregnancy, pre-test eating, smoking, and stress, can impact the test's outcome. Additionally, factors like false positives, false negatives, inaccurate analyses, and others can influence results.
Reference ranges, which help healthcare professionals interpret medical tests, may vary depending on age, gender, and other factors. They may also differ between laboratories due to variations in instruments and methods used. Optimal ranges are designed for preventive purposes, aiming to identify trends and potential risks early, while normal ranges reflect conventional laboratory values indicating no current disease or pathology. Your healthcare practitioner may have specific reasons for testing that deviate from the usual or may interpret results differently based on individual circumstances. Proper interpretation typically involves considering clinical findings and other diagnostic tests. Hence, it is crucial to provide your healthcare professionals with a comprehensive medical history, consult with them for result interpretation, and follow their guidance for potential re-testing or additional diagnostics.
Disclaimer
This content is provided solely for informative and educational purposes. It is not intended as a substitute for medical advice or treatment from a personal physician. Regarding the interpretation of their medical test results and/or specific health questions, it is recommended that all readers and viewers consult their physicians or other qualified health professionals. The publisher is not responsible for any adverse health effects that may result from reading or following the information in this educational content. Before beginning any nutrition, supplement, or lifestyle program, all viewers, especially those taking prescription or over-the-counter medications, should consult their physician or health care practitioner.
Please note that while prominent lab names are included in this content, we cannot guarantee that these labs offer all the tests mentioned. For confirmation, individuals should contact the labs directly or consult their medical practitioners. The information provided reflects general knowledge at the time of publication and may not include recent updates or emerging research. Readers should verify details with qualified professionals to ensure the most up-to-date and accurate guidance.
[1] Rosai J. Rosai and Ackerman's Surgical Pathology. 10th ed. Philadelphia, PA: Elsevier; 2011.
[2] O'Malley FP, Bane AL. The role of core needle biopsy in the diagnosis of breast cancer. Radiol Clin North Am.2000;38(4):759-772.
[3] Lindeman NI, Cagle PT, Beasley MB, et al. Molecular testing guideline for the selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors. Arch Pathol Lab Med. 2013;137(6):828-860.
[4] Renshaw AA, Pinnar N. Comparison of the accuracy of fine-needle aspiration and core needle biopsy for palpable and nonpalpable breast lesions. Arch Pathol Lab Med. 2001;125(8):1053-1056.
[5] Zhou C, Franco LM, Richardson LC. Screening and biopsy follow-up of breast abnormalities. Cancer Control.2018;25(1):107327481775280.
[6] Cibas ES, Ducatman BS. Cytology: Diagnostic Principles and Clinical Correlates. 5th ed. Philadelphia, PA: Elsevier; 2020.
[7] Ellis IO, Humphreys S, Michell M, et al. Guidelines for non-operative diagnostic procedures and reporting in breast cancer screening. Eur J Cancer. 2003;39(4):542-560.
[8] Layfield LJ, Goldstein N. Guidelines for the examination of fine needle aspiration specimens from palpable and nonpalpable breast lesions. Am J Clin Pathol. 1999;111(2):140-145.
[9] Povoski SP, Jimenez RE, Wang WP. Ultrasound-guided core needle biopsy for the diagnosis of breast cancer. World J Surg Oncol. 2007;5:63.
[10] Rubin MA, Zerkowski MP, Camp RL, et al. Analysis of protein expression and gene amplification in cancer using tissue microarray technology. Methods Mol Biol. 2009;520:139-163.
[11] Kuroda N, Ohe C, Mikami Y, et al. Recent advances of immunohistochemistry for diagnosis of renal tumors. Pathol Int. 2013;63(7):381-390.
[12] Alshak NS, Giardino AA, Allen TC. The role of molecular pathology in biopsy interpretation for lung cancer. Arch Pathol Lab Med. 2018;142(3):364-374.
[13] Bonastre J, Jan P, Vergnaud AC, et al. Cost-effectiveness of different biopsy strategies for detecting EGFR mutations in lung cancer. J Thorac Oncol. 2016;11(4):482-491.